Heron Therapeutics Inc
HRTX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$0.35
Today
-2.3%
YTD
-72.8%
About
Operating within the US, Heron Therapeutics Inc is a biotechnology company that develops treatments for pain management and prevention of nausea associated with chemotherapy. Founded in 1983, the company is headquartered in San Diego, California. Heron Therapeutics stock is available on NASDAQ CM, where it is listed under the HRTX ticker. Find out more about HRTX stock by adding it to your eToro portfolio today.
Price chart
Closing price history for HRTX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-1.83
P/S (TTM)0.44
P/B (TTM)11.24
Market cap$65.99M
Cap tierMicro-cap
Industry avg P/E-2.03
Profitability
Gross margin70.07%
EBIT margin-6.99%
Net margin-14.57%
ROEUnknown
ROA-14.06%
Earnings & Revenue
Revenue (TTM)$151.18M
Revenue growth (1Y)+1.0%
EPS (TTM)-$0.19
Free cash flow$-12.13M
Total debt$148.35M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.40
Employees128
Next earnings3 Nov '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.